Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03229759 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth
A Phase 2 study, sponsored by Becton, Dickinson and Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 99
- Enrollment target
NCT03229759 is a Phase 2 study that has completed, run by Becton, Dickinson and Company. The registered enrollment target is 99 participants.
The verdict
NCT03229759, a Phase 2 study, has completed, sponsored by Becton, Dickinson and Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 99 participants
- Enrollment target
Study Summary
Healthy volunteers will receive treatment to two body locations with the investigational product and placebo and the antimicrobial effectiveness of each treatment will be measured.
Interventions
- OTHER Vehicle Control
- OTHER Saline Control
- DRUG Octenidine Dihydrocloride in aqueous solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2017-06-21 |
| Est. Completion | 2017-08-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03229759
The ClinicalTrials.gov registry entry for NCT03229759 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Becton, Dickinson and Company, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vehicle Control is the first listed.
NCT03229759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03229759 about?
NCT03229759 is a clinical study titled "Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth". Healthy volunteers will receive treatment to two body locations with the investigational product and placebo and the antimicrobial effectiveness of each treatment will be measured.
What is the current status of trial NCT03229759?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 99 participants. The study started on 2017-06-21. Estimated completion is 2017-08-04.
What interventions are being tested in trial NCT03229759?
The interventions under investigation include: Vehicle Control (OTHER), Saline Control (OTHER), Octenidine Dihydrocloride in aqueous solution (DRUG).
Who is sponsoring clinical trial NCT03229759?
This trial is sponsored by Becton, Dickinson and Company, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.